SMAD3
MOLECULAR TARGETSMAD family member 3
SMAD3 (SMAD family member 3) is targeted by 63 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SMAD3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 63 compounds. Use the BiohacksAI search to explore all SMAD3 modulators.
About SMAD3 as a Drug Target
SMAD3 (SMAD family member 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 63 compounds with documented SMAD3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SMAD3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.